I listened and watched the shareholder meeting as well as the SVB Conference.
Read all the Proxy Forms which have come out.
As posted in the past, I've taken all the information I could glean and
voted all mine and my mother's votes Against changes (voted the white vote).
I agree that Amarin has put the retail investor on the back shelf and now scrambling to include them in this extremely important time. That is clear. I can live with their treatment if we can eventually sell this company for 8-10 or greater. I also believe that shareholder respect from Amarin will continue to improve.
I don't see however any ideas Sarissa has come up with which would increase the future value of Vaskepa/Vascepa other than a quick significantly discounted sale. Sarissa's latest lies concerned AMRN allegedly purposely asking the registrar NOT to accept the Blue cards. Amarin today sent out a statement by the registrar themselves showing that this once again is a blatant lie or at best twisted significantly to make it appear that Amarin is illegally trying to throw the election.
Before this they said that Amarin purposely delayed getting the voting materials to Sarissa and shareholders and locked in the share owner by date to make it difficult for shareholders to gain back their shares which may have been loaned. Once again Amarin clarified that this is nothing more than lies.
I don't like the way shareholders overall have been dealt with by Amarin but Sarissa is not the answer IMO. The $175ish we are making in UK is not discounted or refunded. That is the price it sales for and right now the formulary coverage is doing great! This by itself will be significant money and over time will fund UK as well as start funding Spain. If Sarissa had negotiated with UK we would be sitting at $125-130/script IMO and if they get control of the board, Spain won't be around 155-160 which I am estimating but will be around 130ish also. That will set the precedent for Italy, Netherlands this year and eventually France next year.
For me it isn't about "gettting even for shafting the shareholder", or "I'll teach those greedy, selfish, arrogant jerks who really owns this company", or "I'm tired of these guys lying to us over and over and collecting shares at our expense". It is about us FINALLY being on the right track after being involved in Amarin for over a decade and maximizing value. I believe they have learned their lesson with treatment of shareholders. I know 99% of those posting on this board don't agree with this assessment. I just want my investment for my mother and my family to be maximized.
We just had 2 of the biggest leading independent proxy firm verify Sarissa's purposes. They also have verified their recommendations on what is the wisest direction for shareholders to vote. I'm not saying that their recommendations alone would be enough to change my vote to Amarin but it should be definitely considered just Iike I try and read the institiutional recommendations on the direction Amarin is going. I didn't vote just because of their recommendations but I do put stock in an independent assessment. I'm not voting where Amarin was in the past but I'm voting from where they are currently will take us. I've taken advantage of the low share price as I did before the Reduce-It results and maximized my shares and now it is just a matter of patiently waiting until around the middle of this decade for the merger and finally be rewarded for this hellish ride.
A couple of predictions,
1. I will predict if Amarin does end up winning that we will hear the same conspiracy theories related to voting in other political arenas which is that Amarin rigged the voting and didn't count all the blue votes. It won't be true but that will be the newest conspiracy theory shared.
2. I also predict if Sarissa gains control we will go up in share price at least initially and if Amarin wins we will go down significantly. When it is sold between 5.75-7.75 we will hear that unfortunately that was all Sarissa could get for Amarin after Amarin management ran it into the ground (even though I believe it could touch 10 plus in BO for those who patiently wait until we've maximized value in EU which also will show our international partner deals that they also can get close to the EU pricing in several of the major international markets.
3. I also believe that we don't move hardly at all SP this year until probably 3rd quarter when we see UK benefits.
4. Also, we just went through the second round of negotiations with Spain. This is a little sooner than I expected. Initally I was saying we have Spain approval by end of May but this could be moved up not to end of April.
I still have Italy and Netherlands by end of October.
France isn't happening this year most likely.
We won't hear much on our partnerships until we get Spain, Italy and Netherlands approval. Once this is set then we will be negotiating with our partners and use the pricing in these countries already approved to negotiate our partnership agreements in the ROW even though the price of V sold in some of the ROW countries will be less.
Also a disclaimer,
I've been wrong MANY times in the past especially with timelines and share price in time. For instance I feel that China will be announced by EO February (and asked for a 2 week reprieve into middle of March in case my 3-4 week closure of PRC d/t Covid was off). KM said that the gov't was closed for a month which I am sure is more accurate and also they had their Chinese New Year. I will admit I am wrong though if like I posted before we don't have a decision by mid March.
Like I said everyone. Let's don't cut off the nose to spite our face when we are just a year from significant share price I believe.
Working a double shift tonight thanks to Judge Du and our wonderful law team's decision with hiring the prominent law firm and holding our trial in Nevada but so be it. We are finally on the right track. Now I just have to go hard a few more years until EU and ROW finally recognize the value of Vascepa.
Best to all longs regardless of the direction you have decided to vote.
AI
